← Eichor
Study identifier: NCT06257030 Synced from ClinicalTrials.gov · July 29, 2026
● Recruiting

The AMARA (As Much As Reasonably Achievable) Study

Condition: Liver Cancer  ·  Sponsor: University Hospital of Patras

PhaseN/A
Planned participants100
Who can joinAll sexes, 18 Years to no upper limit
Healthy volunteersNo

About this study

Subjects with large inoperable liver tumors defined as at least 1 lesion larger than 5cm in maximum diameter. For the purposes of the present study, we define the AMARA principle in intensified regional TARE as a planned irradiated tumor dose \>200Gy by the partition model. The purpose of the study is to evaluate the safety and efficacy of Y90 high dose radioembolization for the management of large inoperable liver tumors. In addition, to correlate the safety and efficacy with the post-treatment dosimetry analysis (by MIM Software Inc) based on 90Y-PET/CT imaging.

This description comes directly from the study's public registry record.

Talk to the study team

Konstantinos Katsanos, Professor  ·  +306978225019  ·  katsanos@med.upatras.gr

Always discuss trial participation with your own doctor first.

Locations (1)

University Hospital of PatrasPátrai, Achaia, GreeceRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT06257030